NEW YORK – Precision oncology firm Genetron Health said last week that it has formed a joint venture and created a new operating center with China's Wuxi municipal government to advance its liver cancer early detection assay, HCCscreen.
NEW YORK – Precision oncology firm Genetron Health said last week that it has formed a joint venture and created a new operating center with China's Wuxi municipal government to advance its liver cancer early detection assay, HCCscreen.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.